The University of Queensland

Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz) (2023–2024)

Grant type:

University of Sydney

Researchers:

• 

  Professor Dan Siskind

  Adjunct Professor
  

  Queensland Brain Institute

  Professor of Psychiatry - NHMRC Eme
  

  Princess Alexandra Hospital Southside Clinical Unit

  Faculty of Medicine

Funded by:

The University of Sydney